Distinguishing Friend from Foe in the Battle Against Cancer

The latest generation of cancer chemotherapeutic drugs specifically targets mutant enzymes or “oncoproteins” that have run amok and now promote uncontrolled cell growth. As promising as these drugs are, cancer cells with their backs against the wall have the tendency to fight back. A major goal of cancer research is to frustrate these acts of cellular desperation.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news77201870.html">Distinguishing Friend from Foe in the Battle Against Cancer</a></p> <p>The latest generation of cancer chemotherapeutic drugs specifically targets mutant enzymes or “oncoproteins” that have run amok and now promote uncontrolled cell growth. As promising as these drugs are, cancer cells with their backs against the wall have the tendency to fight back. A major goal of cancer research is to frustrate these acts of cellular desperation.</p>